Skip to content

The Value of sErum biomarkers in the management of interstitial Lung Disease in patients with connective tissue disease

The Value of sErum biomarkers in the management of interstitial Lung Disease in patients with connective tissue disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120197
Enrollment
Unknown
Registered
2026-03-10
Start date
2026-03-15
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Connective tissue disease - interstitial lung disease

Interventions

Gold Standard:High-Resolution Computed Tomography
Index test:Serum biomarkers

Sponsors

The Affiliated Hospital of Inner Mongolia Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Connective tissue disease includes interstitial lung disease patients hospitalized in Rheumatology and Immunology Department.

Exclusion criteria

Exclusion criteria: Exclusion criteria : 1. patients under 18 years of age; 2. pregnant women; 3. patients who had undergone CT or lung biopsy within the past six months and were proven or ruled out to have ILD; 4. patients with concurrent malignancy or end-stage liver or kidney failure.

Design outcomes

Primary

MeasureTime frame
Diagnostic accuracy;

Secondary

MeasureTime frame
Positive likelihood ratio;Negative likelihood ratio;Diagnostic Odds Ratio;Positive Predictive Value;Negative predictive value;

Countries

China

Contacts

Public ContactZhide Hu

The Affiliated Hospital of Inner Mongolia Medical University

hzdlj81@163.com+86 471 345 2047

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026